Ensign Peak Advisors
NVCR icon

Ensign Peak Advisors’s NovoCure NVCR Stock Holding History

Ensign Peak Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Hold
6,737
– – ﹤0.01% 1612
2026
Q1 		$73.4K Hold
6,737
– – ﹤0.01% 1628
2025
Q4 		$87.1K Sell
6,737
-21,350
-76% -$274K ﹤0.01% 1604
2025
Q3 		$363K Sell
28,087
-10,200
-27% -$136K ﹤0.01% 1518
2025
Q2 		$682K Sell
38,287
-850
-2% -$14.8K ﹤0.01% 1453
2025
Q1 		$697K Hold
39,137
– – ﹤0.01% 1435
2024
Q4 		$1.17M Hold
39,137
– – ﹤0.01% 1227
2024
Q3 		$612K Hold
39,137
– – ﹤0.01% 1552
2024
Q2 		$670K Buy
39,137
+2,400
+7% +$42.2K ﹤0.01% 1510
2024
Q1 		$574K Sell
36,737
-6,028
-14% -$88.7K ﹤0.01% 1589
2023
Q4 		$638K Sell
42,765
-13,630
-24% -$182K ﹤0.01% 1601
2023
Q3 		$911K Buy
56,395
+21,625
+62% +$623K ﹤0.01% 1273
2023
Q2 		$1.44M Buy
34,770
+5,280
+18% +$328K ﹤0.01% 1006
2023
Q1 		$1.77M Buy
29,490
+650
+2% +$51.9K ﹤0.01% 890
2022
Q4 		$2.12M Buy
28,840
+4,200
+17% +$316K ﹤0.01% 791
2022
Q3 		$1.87M Hold
24,640
– – ﹤0.01% 805
2022
Q2 		$1.71M Hold
24,640
– – ﹤0.01% 862
2022
Q1 		$2.04M Sell
24,640
-7,030
-22% -$518K ﹤0.01% 882
2021
Q4 		$2.38M Buy
31,670
+24,305
+330% +$2.44M ﹤0.01% 897
2021
Q3 		$856K Buy
7,365
+1,355
+23% +$205K ﹤0.01% 1485
2021
Q2 		$1.33M Buy
+6,010
New +$1.17M ﹤0.01% 1328

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Ensign Peak Advisors's NVCR Position: Q2 2026 in Review

Ensign Peak Advisors held its NovoCure (NVCR) position steady in Q2 2026 at 6,737 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

Ensign Peak Advisors first reported a position in NVCR in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.38M in Q4 2021. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Ensign Peak Advisors held 6,737 shares of NovoCure worth $102K as of Q2 2026.
  • Ensign Peak Advisors left its NovoCure share count unchanged in Q2 2026.
  • NovoCure made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1612 holding.
  • Ensign Peak Advisors first reported a position in NovoCure in Q2 2021 and has held it in 21 quarters since.
  • Ensign Peak Advisors's NovoCure position peaked at $2.38M in Q4 2021.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.